← Back to Search

Parental Control for Disruptive Behavior in Children

N/A
Recruiting
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Study Summary

This trial looks at whether letting a child have their way sometimes, and not other times, helps to decrease destructive behavior.

Who is the study for?
This trial is for boys and girls aged 3 to 17 with disruptive behaviors, who experience problem behavior at least 10 times a day despite treatment. They must be on stable medication or drug-free, have consistent protective supports like helmets, and a steady educational plan. Those getting extensive current treatment or with conditions like Rett syndrome can't participate.Check my eligibility
What is being tested?
The study tests if alternating 'on' sessions where the child gets their way with 'off' sessions where they don't can reduce relapse of destructive behavior when caregivers are unavailable. It compares this approach (CDT) against standard control methods in managing aggression and self-harm.See study design
What are the potential side effects?
Since the interventions involve behavioral strategies rather than medications, there are no direct side effects like those seen with drugs. However, changes in behavior patterns could potentially lead to increased frustration or stress during adjustment periods.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of problem behavior during resurgence test
Secondary outcome measures
Number of participants with resurgence
Number of sessions to criterion

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Contingency-Discrimintation Training (CDT)Experimental Treatment1 Intervention
In this condition, the clinician will alternate sessions with reinforcement for the alternative response and sessions without reinforcement for the alternative response during extinction treatment of problem behavior. According to RaC2, alternating periods of reinforcer availability and unavailability for the alternative response will teach the participant that the alternative response alone produces reinforcement but not always. The investigators predict that resurgence of problem behavior will lower, shorter lasting, and with fewer participants experiencing resurgence than those in the control group.
Group II: ControlActive Control1 Intervention
This condition emulates a traditional approach to treatment in which the clinician does not alternate sessions with reinforcement for the alternative response and sessions without reinforcement for the alternative response during extinction treatment of problem behavior. The investigators predict that resurgence of problem behavior will higher, longer lasting, and with more participants experiencing resurgence than those in the CDT group.

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
429 Previous Clinical Trials
64,202 Total Patients Enrolled

Media Library

CDT Clinical Trial Eligibility Overview. Trial Name: NCT05537610 — N/A
Disruptive Behaviors Research Study Groups: Contingency-Discrimintation Training (CDT), Control
Disruptive Behaviors Clinical Trial 2023: CDT Highlights & Side Effects. Trial Name: NCT05537610 — N/A
CDT 2023 Treatment Timeline for Medical Study. Trial Name: NCT05537610 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial accept participants of a younger age bracket?

"This clinical trial will include any minors between the ages of 3 and 17."

Answered by AI

Are there any openings available for participants in this trial?

"Per the information posted on clinicaltrials.gov, this medical trial is not currently enrolling participants. Initially presented on February 1st 2023 and last edited September 12th 2022, it does not appear to be soliciting any new candidates at present; however, there are 217 other trials actively recruiting patients now."

Answered by AI

What criteria must participants meet to be considered for this clinical trial?

"The criteria for enrolment into this research project requires participants to exhibit behavioural abnormalities and be between the ages of 3-17. In total, we are recruiting 30 individuals who meet these requirements."

Answered by AI

Who else is applying?

What state do they live in?
California
What site did they apply to?
Children's Specialized Hospital-Rutgers University Center for Autism Research, Education, and Services
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
2
Recent research and studies
clinicaltrials.govStudy
Extensions of Resurgence as Choice
Brian D. Greer, Ph.D., BCBA-D 2023. "Extensions of Resurgence as Choice". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05537610.
~20 spots leftby Nov 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top